176 related articles for article (PubMed ID: 18822361)
1. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.
Cao SL; Ren XW; Zhang QZ; Chen E; Xu F; Chen J; Liu LC; Jiang XG
Int J Pharm; 2009 Jan; 365(1-2):109-15. PubMed ID: 18822361
[TBL] [Abstract][Full Text] [Related]
2. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
[TBL] [Abstract][Full Text] [Related]
3. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
[TBL] [Abstract][Full Text] [Related]
4. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; Lund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q
Otolaryngol Head Neck Surg; 1998 May; 118(5):648-54. PubMed ID: 9591864
[TBL] [Abstract][Full Text] [Related]
5. [Clinicofunctional parallels in the treatment of allergic rhinitis with mometasone furoate].
Kozlov VS; Derzhavina LL; Kramnoĭ AI
Vestn Otorinolaringol; 2006; (2):44-8. PubMed ID: 16710184
[No Abstract] [Full Text] [Related]
6. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
7. Daily versus self-adjusted dosing of topical mometasone furoate nasal spray in patients with allergic rhinitis: randomised, controlled trial.
Khan MA; Abou-Halawa AS; Al-Robaee AA; Alzolibani AA; Al-Shobaili HA
J Laryngol Otol; 2010 Apr; 124(4):397-401. PubMed ID: 19930776
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of allergic rhinitis with nasal mometasone furoate].
Zhang L; Xu G; Wang XD; Liu SX; Li Y; Wang SQ; Yang BB; Zheng CQ; Wang CS; Dong P; Lin ZP; Zhang H; Han DM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):455-9. PubMed ID: 19954014
[TBL] [Abstract][Full Text] [Related]
9. [The effect of mometasone furoate on mucociliary clearance in patients with perennial allergic rhinitis].
Pata YS; Akbaş Y; Unal M; Görür K; Ozcan C; Vayisoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2003 Oct; 11(4):97-9. PubMed ID: 15493336
[TBL] [Abstract][Full Text] [Related]
10. Influence of treatment with intranasal corticosteroids on the nasal mucosa, weight, and corticosteroid concentration in rats.
Park DM; Carvalho TL; Franci JA; Anselmo-Lima WT
Am J Rhinol Allergy; 2012; 26(1):e46-9. PubMed ID: 22182666
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate: a review of its intranasal use in allergic rhinitis.
Baldwin CM; Scott LJ
Drugs; 2008; 68(12):1723-39. PubMed ID: 18681494
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.
Baena-Cagnani CE; Patel P
Curr Med Res Opin; 2010 Sep; 26(9):2047-55. PubMed ID: 20629597
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
[TBL] [Abstract][Full Text] [Related]
15. The effect of topical mometasone furoate nasal spray on carriage of Staphylococcus aureus.
Polat C; Uysal EB; Yüce S; Uysal IO; Koç S
Kulak Burun Bogaz Ihtis Derg; 2014; 24(1):1-5. PubMed ID: 24798432
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
17. Mometasone furoate nasal spray for the treatment of elderly patients with perennial allergic rhinitis.
Grossman J; Gates D
Ann Allergy Asthma Immunol; 2010 May; 104(5):452-3. PubMed ID: 20486338
[No Abstract] [Full Text] [Related]
18. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
19. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
Altuntaş E; Yener G
AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
[TBL] [Abstract][Full Text] [Related]
20. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Bachert C; El-Akkad T
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
